Yewei Zhang

2.8k total citations · 1 hit paper
45 papers, 2.4k citations indexed

About

Yewei Zhang is a scholar working on Biomedical Engineering, Materials Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yewei Zhang has authored 45 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Biomedical Engineering, 21 papers in Materials Chemistry and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yewei Zhang's work include Nanoplatforms for cancer theranostics (33 papers), Advanced Nanomaterials in Catalysis (12 papers) and Photodynamic Therapy Research Studies (8 papers). Yewei Zhang is often cited by papers focused on Nanoplatforms for cancer theranostics (33 papers), Advanced Nanomaterials in Catalysis (12 papers) and Photodynamic Therapy Research Studies (8 papers). Yewei Zhang collaborates with scholars based in China, Singapore and New Zealand. Yewei Zhang's co-authors include Xiaochen Dong, Jianhua Zou, Jinjun Shao, Wei Huang, Weili Si, Qi Zhang, Gongyuan Liu, Qianyun Tang, Peng Chen and Xiaoyan Yang and has published in prestigious journals such as Biomaterials, Chemical Communications and Chemical Engineering Journal.

In The Last Decade

Yewei Zhang

45 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surface Modified Ti₃C₂ MXene Nanosheets for Tumor Targeting Photothermal/Photodynamic/Chemo Synergistic Therapy

2017 573 citations Gongyuan Liu, Jianhua Zou et al. ACS Applied Materials & Interfaces profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yewei Zhang China	26	1.8k	1.4k	504	391	383	45	2.4k
Jin‐Yue Zeng China	20	1.7k 1.0×	1.2k 0.9×	487 1.0×	444 1.1×	321 0.8×	27	2.4k
Caihong Dong China	29	1.7k 1.0×	1.1k 0.8×	651 1.3×	468 1.2×	237 0.6×	41	2.4k
Bo‐Ru Xie China	18	1.5k 0.9×	1.1k 0.8×	456 0.9×	467 1.2×	325 0.8×	21	2.0k
Peiran Zhao China	22	1.8k 1.0×	1.4k 1.0×	505 1.0×	609 1.6×	224 0.6×	48	2.5k
Bei Liu China	25	1.9k 1.1×	1.4k 1.0×	644 1.3×	520 1.3×	299 0.8×	49	2.6k
Wenting Li China	26	2.0k 1.2×	1.0k 0.8×	565 1.1×	725 1.9×	435 1.1×	61	2.6k
Ping Hu China	27	1.9k 1.1×	1.2k 0.9×	693 1.4×	614 1.6×	434 1.1×	62	2.8k
Yinchu Ma China	24	1.6k 0.9×	812 0.6×	634 1.3×	605 1.5×	342 0.9×	34	2.2k
Weiwei Zeng China	24	1.5k 0.9×	1.0k 0.7×	498 1.0×	433 1.1×	221 0.6×	47	2.1k
Weitao Yang China	29	1.8k 1.0×	1.4k 1.0×	625 1.2×	663 1.7×	353 0.9×	69	2.7k

Countries citing papers authored by Yewei Zhang

Since Specialization

Citations

This map shows the geographic impact of Yewei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yewei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yewei Zhang more than expected).

Fields of papers citing papers by Yewei Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yewei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yewei Zhang. The network helps show where Yewei Zhang may publish in the future.

Co-authorship network of co-authors of Yewei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yewei Zhang. A scholar is included among the top collaborators of Yewei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yewei Zhang. Yewei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Xin, Yunxin Li, Yanlong Shi, et al.. (2025). The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovascular Diabetology. 24(1). 200–200. 9 indexed citations

Liu, Shiwei, et al.. (2025). Global research trends on nanotechnology and colorectal cancer: a two-decade analysis. Nanomedicine. 20(4). 343–354. 1 indexed citations

Liu, Shiwei, et al.. (2025). An aptamer-conjugated mesoporous polydopamine formulation for synergistic targeted and photothermal therapy of hepatocellular carcinoma. International Journal of Pharmaceutics X. 9. 100335–100335. 1 indexed citations

Peng, Hao, et al.. (2024). An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness. APOPTOSIS. 29(5-6). 898–919. 1 indexed citations

Lu, Yao, et al.. (2023). Rapid improvement of heart repair in rats after myocardial infarction by precise magnetic stimulation on the vagus nerve with an injectable magnetic hydrogel. Nanoscale. 15(7). 3532–3541. 26 indexed citations

Zhang, Yewei, et al.. (2023). A Low-Power In-Memory Multiplication and Accumulation Array With Modified Radix-4 Input and Canonical Signed Digit Weights. IEEE Transactions on Very Large Scale Integration (VLSI) Systems. 31(11). 1700–1712. 1 indexed citations

Zhou, Zihan, Lei Jin, Xiaowen Li, et al.. (2023). TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC. Biology Direct. 18(1). 18–18. 24 indexed citations

Yang, Nan, Hui Li, Changyu Cao, et al.. (2022). Tumor microenvironment-activated theranostic nanoreactor for NIR-II Photoacoustic imaging-guided tumor-specific photothermal therapy. Fundamental Research. 4(1). 178–187. 22 indexed citations

Shi, Yanlong, Guo Huang, Fei Jiang, et al.. (2022). Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma. Frontiers in Immunology. 13. 1070593–1070593. 12 indexed citations

10.

Peng, Hao, et al.. (2022). Advances of cancer-associated fibroblasts in liver cancer. Biomarker Research. 10(1). 59–59. 52 indexed citations

11.

Huang, Han, Xiaorui Wang, Weili Wang, et al.. (2021). Injectable hydrogel for postoperative synergistic photothermal-chemodynamic tumor and anti-infection therapy. Biomaterials. 280. 121289–121289. 102 indexed citations

12.

Ge, Wei, Chao Liu, Yewei Zhang, et al.. (2021). Structural effect of NIR-II absorbing charge transfer complexes and its application on cysteine-depletion mediated ferroptosis and phototherapy. Journal of Materials Chemistry B. 9(39). 8300–8307. 17 indexed citations

13.

Yin, Jiajia, Xiaorui Wang, Xu Sun, et al.. (2021). Thrombin Based Photothermal‐Responsive Nanoplatform for Tumor‐Specific Embolization Therapy. Small. 17(52). e2105033–e2105033. 26 indexed citations

14.

Zhou, Pengcheng, Yuhua Lu, Yewei Zhang, & Lei Wang. (2021). Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma. Frontiers in Oncology. 11. 661758–661758. 47 indexed citations

15.

Xin, Qing, et al.. (2021). Emerging treatment modalities for systemic therapy in hepatocellular carcinoma. Biomarker Research. 9(1). 64–64. 18 indexed citations

16.

Zhu, Jiawei, Aihong Jiao, Xinyi Lv, et al.. (2021). Mitochondrial Ca2+-overloading by oxygen/glutathione depletion-boosted photodynamic therapy based on a CaCO3 nanoplatform for tumor synergistic therapy. Acta Biomaterialia. 137. 252–261. 57 indexed citations

17.

Zou, Jianhua, Lei Xue, Nan Yang, et al.. (2019). A glutathione responsive pyrrolopyrrolidone nanotheranostic agent for turn-on fluorescence imaging guided photothermal/photodynamic cancer therapy. Materials Chemistry Frontiers. 3(10). 2143–2150. 27 indexed citations

18.

Shi, Huaxia, Rui Gu, Wenjing Xu, et al.. (2019). Near-Infrared Light-Harvesting Fullerene-Based Nanoparticles for Promoted Synergetic Tumor Phototheranostics. ACS Applied Materials & Interfaces. 11(48). 44970–44977. 36 indexed citations

19.

Wang, Ya, Xiaoyu Huang, Yunyun Tang, et al.. (2018). A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy. Chemical Science. 9(42). 8103–8109. 114 indexed citations

20.

Liu, Gongyuan, Jianhua Zou, Qianyun Tang, et al.. (2017). Surface Modified Ti₃C₂ MXene Nanosheets for Tumor Targeting Photothermal/Photodynamic/Chemo Synergistic Therapy. ACS Applied Materials & Interfaces. 9(46). 40077–40086. 573 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact